RNAi Degrades the SARS-CoV-2 Spike Protein RNA for Developing Drugs to Treat COVID-19

RNAi Degrades the SARS-CoV-2 Spike Protein RNA for Developing Drugs to Treat COVID-19

COVID-19 is caused by severe acute respiratory SARS-CoV-2. Regardless of the availability of treatment strategies for COVID-19, effective therapy will remain essential. A promising approach to tackle the SARS-CoV-2 could be small interfering (si) RNAs. Here we designed the small hairpin RNA (named a...

Full description

Bibliographic Details
Main Authors: Weiwei Zhang, Linjia Huang, Jumei Huang, Xin Jiang, Xiaohong Ren, Xiaojie Shi, Ling Ye, Shuhui Bian, Jianhe Sun, Yufeng Gao, Zehua Hu, Lintin Guo, Suyan Chen, Jiahao Xu, Jie Wu, Jiwen Zhang, Daxiang Cui, Fangping Dai
Format: Article
Language:English
Published: Tsinghua University Press 2022-06-01
Series:Nano Biomedicine and Engineering
Subjects:
covid-19
rnai
nanoparticles
shrna
plasmids
Online Access:https://www.sciopen.com/article/10.5101/nbe.v14i2.p173-185

Internet

https://www.sciopen.com/article/10.5101/nbe.v14i2.p173-185

Similar Items